The impact of the COVID-19 pandemic on the small cell lung cancer epidemiology
Differences in some clinicopathologic factors and treatment choices, or the pandemic itself, may result in a tendency for patients with SCLC diagnosed after the pandemic to have a worse prognosis, alerting clinicians to the need to focus on the management and treatment of this population.
Authors
- Lele Chang (ORCID: https://orcid.org/0000-0002-1305-9058)
- Xuemei Zhang (ORCID: https://orcid.org/0000-0003-0705-4231)
- Wansu Xu (ORCID: https://orcid.org/0009-0003-5419-9879)
Institutions
- Fujian Medical University (CN)
- Quzhou City People's Hospital (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1007/s12672-025-02816-5
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 1.05